428 related articles for article (PubMed ID: 37289660)
1. Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023.
Kota KK; Chesson H; Hong J; Zelaya C; Spicknall IH; Riser AP; Hurley E; Currie DW; Lash RR; Carnes N; Concepción-Acevedo J; Ellington S; Belay ED; Mermin J
MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):627-632. PubMed ID: 37289660
[TBL] [Abstract][Full Text] [Related]
2. Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males - United States, May-December 2022.
Kota KK; Hong J; Zelaya C; Riser AP; Rodriguez A; Weller DL; Spicknall IH; Kriss JL; Lee F; Boersma P; Hurley E; Hicks P; Wilkins C; Chesson H; Concepción-Acevedo J; Ellington S; Belay E; Mermin J
MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(15):398-403. PubMed ID: 37053122
[TBL] [Abstract][Full Text] [Related]
3. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
[TBL] [Abstract][Full Text] [Related]
4. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
[TBL] [Abstract][Full Text] [Related]
6. Reducing Vaccination Disparities During a National Emergency Response: The US Mpox Vaccine Equity Pilot Program.
Bautista GJ; Madera-Garcia V; Carter RJ; Schwitters A; Byrkit R; Carnes N; Prejean J;
J Public Health Manag Pract; 2024 Jan-Feb 01; 30(1):122-129. PubMed ID: 37678261
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
[TBL] [Abstract][Full Text] [Related]
8. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
[TBL] [Abstract][Full Text] [Related]
9. Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response - United States, May 17-October 6, 2022.
Kava CM; Rohraff DM; Wallace B; Mendoza-Alonzo JL; Currie DW; Munsey AE; Roth NM; Bryant-Genevier J; Kennedy JL; Weller DL; Christie A; McQuiston JH; Hicks P; Strid P; Sims E; Negron ME; Iqbal K; Ellington S; Smith DK
MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1449-1456. PubMed ID: 36355615
[TBL] [Abstract][Full Text] [Related]
10. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
[TBL] [Abstract][Full Text] [Related]
11. Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022.
Philpott D; Hughes CM; Alroy KA; Kerins JL; Pavlick J; Asbel L; Crawley A; Newman AP; Spencer H; Feldpausch A; Cogswell K; Davis KR; Chen J; Henderson T; Murphy K; Barnes M; Hopkins B; Fill MA; Mangla AT; Perella D; Barnes A; Hughes S; Griffith J; Berns AL; Milroy L; Blake H; Sievers MM; Marzan-Rodriguez M; Tori M; Black SR; Kopping E; Ruberto I; Maxted A; Sharma A; Tarter K; Jones SA; White B; Chatelain R; Russo M; Gillani S; Bornstein E; White SL; Johnson SA; Ortega E; Saathoff-Huber L; Syed A; Wills A; Anderson BJ; Oster AM; Christie A; McQuiston J; McCollum AM; Rao AK; Negrón ME;
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1018-1022. PubMed ID: 35951487
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccination Coverage, by Race and Ethnicity - National Immunization Survey Adult COVID Module, United States, December 2020-November 2021.
Kriss JL; Hung MC; Srivastav A; Black CL; Lindley MC; Lee JT; Koppaka R; Tsai Y; Lu PJ; Yankey D; Elam-Evans LD; Singleton JA
MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(23):757-763. PubMed ID: 35679179
[TBL] [Abstract][Full Text] [Related]
13. Alternative Methods for Grouping Race and Ethnicity to Monitor COVID-19 Outcomes and Vaccination Coverage.
Yoon P; Hall J; Fuld J; Mattocks SL; Lyons BC; Bhatkoti R; Henley J; McNaghten AD; Daskalakis D; Pillai SK
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1075-1080. PubMed ID: 34383729
[TBL] [Abstract][Full Text] [Related]
14. Mpox Knowledge, Attitudes, and Practices Among Persons Presenting for JYNNEOS Vaccination-District of Columbia, August to October 2022.
Hassan R; Wondmeneh S; Gonzalez Jimenez N; Chapman K; Mangla A; Ashley P; Willut C; Lee M; Rhodes T; Gillani S; Copen C; Jackson DA; Waltenburg M; Delaney KP; Miles G; Agnew-Brune C; Oakley LP;
Sex Transm Dis; 2024 Jan; 51(1):47-53. PubMed ID: 37921836
[TBL] [Abstract][Full Text] [Related]
15. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
Gilbert M; Ablona A; Chang HJ; Grennan T; Irvine MA; Sarai Racey C; Salway T; Naus M; Dawar M; Ogilvie G
Vaccine; 2023 Apr; 41(15):2485-2494. PubMed ID: 36894397
[TBL] [Abstract][Full Text] [Related]
16. A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events - Georgia, August 27-September 5, 2022.
Millman AJ; Denson DJ; Allen ML; Malone JA; Daskalakis DC; Durrence D; Rustin RC; Toomey KE;
MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1382-1883. PubMed ID: 36301799
[TBL] [Abstract][Full Text] [Related]
17. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study.
Bertran M; Andrews N; Davison C; Dugbazah B; Boateng J; Lunt R; Hardstaff J; Green M; Blomquist P; Turner C; Mohammed H; Cordery R; Mandal S; Campbell C; Ladhani SN; Ramsay M; Amirthalingam G; Bernal JL
Lancet Infect Dis; 2023 Jul; 23(7):828-835. PubMed ID: 36924787
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Disparities in COVID-19 Incidence by Age, Sex, and Period Among Persons Aged <25 Years - 16 U.S. Jurisdictions, January 1-December 31, 2020.
Van Dyke ME; Mendoza MCB; Li W; Parker EM; Belay B; Davis EM; Quint JJ; Penman-Aguilar A; Clarke KEN
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(11):382-388. PubMed ID: 33735165
[TBL] [Abstract][Full Text] [Related]
20. Modifications to Sexual Behaviors Associated With Mpox (Monkeypox) Virus Transmission Among Persons Presenting for mpox Vaccination, Washington, DC, August-October, 2022.
Copen CE; Delaney KP; Agnew-Brune C; Berry I; Griffin I; Hassan R; Oakley LP; Wondmeneh S; Rhodes T; Gillani S; Lee M; Ashley P; Willut C; Mangla AT; Waltenburg MA; Jackson DA;
Sex Transm Dis; 2024 Jan; 51(1):54-60. PubMed ID: 37889944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
